Effects of Vildagliptine and Glimepiride on Glucose Variability

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to analyze the differences of blood sugar level and glycemic variability between sulfonylurea and DPP-4 inhibitor groups applying CGMS for a chosen number of type 2 DM patients. The investigators also reveal influences of each drugs on cardiovascular risk factors by measuring related biomarkers.
Epistemonikos ID: e9d43fe44ea25b4747f7a6b0fc84c38cc325a080
First added on: May 11, 2024